Yellow Fever: Clinical Trials

1 trial for Yellow Fever, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19
Galidesivir, Placebo - COVID-19, Yellow Fever
Phase 1TerminatedBioCryst Pharmaceuticals242020-04-092021-05-27

Narrower conditions

COVID-19 (1)

Broader conditions

Arbovirus Infections (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Flaviviridae Infections (1)  ·  Flavivirus Infections (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mosquito-Borne Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

galidesivir (1)

Sponsors

BioCryst Pharmaceuticals (1)

Countries

Brazil (1)

Top investigators

Esper Kallas, MD, PhD (1)

NIH funding

272201300017C-18-0-1 (1)